Tri Locum Partners LP Buys Baxter International Inc, Seagen Inc, Merck Inc, Sells Regeneron Pharmaceuticals Inc, Jazz Pharmaceuticals PLC, Protagonist Therapeutics Inc

• New Purchases: BAX, SGEN, MRK, SKIN, SRPT, LEGN, LPTX, UTHR, XENE, BNTX, TBPH, CCXI,
• Added Positions: EW, ISEE, BLU, EGRX, CYCC, HZNP,
• Reduced Positions: REGN, MDT, WBA, AVDL, LSAQ,
• Sold Out: JAZZ, PTGX, JNJ, CI, ALDX, PFE, EOLS, ITCI, CLDX, HUM, MRNA, MREO, ARGX,

For the details of Tri Locum Partners LP's stock buys and sells, go to https://www.gurufocus.com/guru/tri+locum+partners+lp/current-portfolio/portfolio

1. Horizon Therapeutics PLC (HZNP) - 261,500 shares, 11.38% of the total portfolio. Shares added by 1.45%
2. Baxter International Inc (BAX) - 312,400 shares, 9.98% of the total portfolio. New Position
3. Walgreens Boots Alliance Inc (WBA) - 350,000 shares, 6.54% of the total portfolio.
4. Seagen Inc (SGEN) - 96,307 shares, 6.50% of the total portfolio. New Position
5. Walgreens Boots Alliance Inc (WBA) - 312,847 shares, 5.85% of the total portfolio. Shares reduced by 26.5%

Tri Locum Partners LP initiated holding in Baxter International Inc. The purchase prices were between $73.77 and $83.61, with an estimated average price of $79.12. The stock is now traded at around $79.510000. The impact to a portfolio due to this purchase was 9.98%. The holding were 312,400 shares as of 2021-09-30.

Tri Locum Partners LP initiated holding in Seagen Inc. The purchase prices were between $142.45 and $169.82, with an estimated average price of $155.61. The stock is now traded at around $179.590000. The impact to a portfolio due to this purchase was 6.5%. The holding were 96,307 shares as of 2021-09-30.

Tri Locum Partners LP initiated holding in Merck & Co Inc. The purchase prices were between $71.68 and $78.83, with an estimated average price of $76.11. The stock is now traded at around $84.180000. The impact to a portfolio due to this purchase was 5.43%. The holding were 181,765 shares as of 2021-09-30.

Tri Locum Partners LP initiated holding in The Beauty Health Co. The purchase prices were between $16.76 and $28.26, with an estimated average price of $22.02. The stock is now traded at around $26.840000. The impact to a portfolio due to this purchase was 5.21%. The holding were 504,606 shares as of 2021-09-30.

Tri Locum Partners LP initiated holding in Sarepta Therapeutics Inc. The purchase prices were between $65.97 and $92.48, with an estimated average price of $77.05. The stock is now traded at around $83.520000. The impact to a portfolio due to this purchase was 4.96%. The holding were 135,055 shares as of 2021-09-30.

Tri Locum Partners LP initiated holding in Legend Biotech Corp. The purchase prices were between $35.31 and $50.56, with an estimated average price of $41.56. The stock is now traded at around $54.420000. The impact to a portfolio due to this purchase was 3.38%. The holding were 168,467 shares as of 2021-09-30.

Tri Locum Partners LP added to a holding in Edwards Lifesciences Corp by 154.58%. The purchase prices were between $102.91 and $122.75, with an estimated average price of $114.13. The stock is now traded at around $117.370000. The impact to a portfolio due to this purchase was 3.36%. The holding were 122,880 shares as of 2021-09-30.

Tri Locum Partners LP added to a holding in IVERIC bio Inc by 290.11%. The purchase prices were between $7.07 and $17.5, with an estimated average price of $10.82. The stock is now traded at around $16.455000. The impact to a portfolio due to this purchase was 1.81%. The holding were 377,708 shares as of 2021-09-30.

Tri Locum Partners LP added to a holding in BELLUS Health Inc by 159.11%. The purchase prices were between $2.7 and $6.64, with an estimated average price of $3.78. The stock is now traded at around $6.420000. The impact to a portfolio due to this purchase was 1.46%. The holding were 972,997 shares as of 2021-09-30.

Tri Locum Partners LP added to a holding in Eagle Pharmaceuticals Inc by 29.06%. The purchase prices were between $43.79 and $55.78, with an estimated average price of $49.16. The stock is now traded at around $50.860000. The impact to a portfolio due to this purchase was 0.61%. The holding were 122,503 shares as of 2021-09-30.

Tri Locum Partners LP added to a holding in Cyclacel Pharmaceuticals Inc by 66.90%. The purchase prices were between $4.54 and $6.02, with an estimated average price of $5.36. The stock is now traded at around $4.780000. The impact to a portfolio due to this purchase was 0.44%. The holding were 522,943 shares as of 2021-09-30.

Tri Locum Partners LP sold out a holding in Jazz Pharmaceuticals PLC. The sale prices were between $128.64 and $184.79, with an estimated average price of $151.34.

Tri Locum Partners LP sold out a holding in Protagonist Therapeutics Inc. The sale prices were between $12.95 and $49.69, with an estimated average price of $42.78.

Tri Locum Partners LP sold out a holding in Johnson & Johnson. The sale prices were between $161.5 and $179.47, with an estimated average price of $170.65.

Tri Locum Partners LP sold out a holding in Cigna Corp. The sale prices were between $200.16 and $238.3, with an estimated average price of $217.75.

Tri Locum Partners LP sold out a holding in Aldeyra Therapeutics Inc. The sale prices were between $7.94 and $11.31, with an estimated average price of $9.2.

Tri Locum Partners LP sold out a holding in Pfizer Inc. The sale prices were between $39.25 and $50.42, with an estimated average price of $44.27.